A Therapeutic Nipple Shield (TNS) was previously developed to respond to the global need for new infant drug delivery technologies. However, the release efficiency for the same Active Pharmaceutical Ingredient (API) from different therapeutic matrices within the TNS formulation has not yet been investigated. To address this, in-vitro release of elemental zinc into human milk from two types of Texel non-woven fibre mats of varying thickness and different gram per square meter values, placed inside the TNS was explored and compared to the release from zinc-containing rapidly disintegrating tablets. In-vitro delivery was performed by means of a breastfeeding simulation apparatus, with human milk flow rates and suction pressure adjusted to physiologically relevant values, and release was quantified using Inductively Coupled Plasma Optical Emission Spectrometry (ICP-OES). It was found that a total recovery of 62 -64 % elemental zinc was obtained after the human milk had passed through the fibre insert, amounting to a 20 -48% increase compared to previous zinc delivery studies using rapidly disintegrating tablets within the TNS. This indicates that non-woven Texel fibre mats were identified as the superior dosage form for zinc oral drug delivery into human milk using a TNS.
Introduction
New infant drug delivery technologies are urgently needed. According to the World Health Organization (WHO), many of the 5.9 million child deaths worldwide before the age of five could be prevented by enabling access to affordable interventions, capable of addressing the current challenges of low-resource settings, such as lack of potable water or sterilisation (IGME, 2015; World Health Organization, 2007) . This clearly indicates that novel, affordable and easy-to-use infant drug delivery technologies are urgently needed. To address current limitations, a Therapeutic Nipple Shield (TNS) was developed (Gerrard et al., 2012) , which enables the delivery of Active Pharmaceutical Ingredients (APIs) during breastfeeding. It consists of a nipple shield device containing a therapeutic insert, for example in the form of an API-loaded tablet or fibrous material. When worn by a mother during breastfeeding, such a device enriches the human milk consumed by the suckling infant with medication or nutrients (see Figure 1 ) (Gerrard et al., 2012) . The TNS has the potential to dramatically change the way drugs are administered to infants worldwide, as it could potentially improve the acceptability of pharmaceutical products in both developed and developing countries (Lopez and Ernest, 2015) , and offer an alternative to conventional drug delivery for the 36 % of infants aged 0 -6 months, who are exclusively breastfed (World Health Organization, 2017) .
Zinc is a physiologically important element, responsible for the activity of various proteins in major pathways of the human metabolism (Terrin et al., 2015) . Its deficiency has extensive effects on growth and development of infants, as well as the capabilities of the body's immune system (Caulfield et al., 1998; Terrin et al., 2015; Wulf et al., 2013) . The intestinal absorption of zinc is independent of zinc status, yet higher uptake is reported for term babies as a result of lower zinc concentration in the blood serum (Terrin et al., 2015) . Preterm and Small for Gestational Age (SGA) neonates have an increased risk of zinc deficiency (Wulf et al., 2013) , which is believed to occur within the first 1 -2 months of life (Caulfield et al., 1998) .
Breastfeeding infants obtain zinc through the consumption of human milk, however, zinc concentration can exhibit significant variations (0.7 -1.6 mg l -1 ), and constantly declines postpartum:
8 -12 mg l -1 zinc can be found in colostrum, the first milk the maternal breast produces after giving birth, 3 -6 mg l -1 in human milk seven days after birth, and only 1-3 mg l -1 an additional three weeks later (Terrin et al., 2015) . To prevent deficiency, enteral delivery of zinc is recommended, being 0.8 mg kg -1 day -1 for term infants and 3 mg kg -1 day -1 for preterm neonates (Hambidge and Krebs, 2004) . If zinc deficiency occurs, it is associated with conditions such as dermatitis, growth retardation, necrotizing enterocolitis, neurologic damage, bronchopulmonary dysplasia, infections, and retinopathy of prematurity (Terrin et al., 2015) . It is recognized that not only severe, but also moderate zinc deficiency is adding to "the total burden of disease" in infants leading to about 800,000 child deaths every year (Black, 2003) .
In addition to zinc's general health promoting effects, the WHO recommends use of zinc (20 mg zinc sulphate) as an adjunct supplement to oral rehydration salts for the treatment of acute diarrhoea (World Health Organization, 2015) . Due to the significance of zinc for the physical development and wellbeing of infants globally, its delivery into human milk using the TNS was investigated in this study.
To aid in-vitro testing of the TNS, a breastfeeding simulation apparatus was developed by
Gerrard et al., simulating both the process of lactation and infant feeding by mimicking the average flow rates/patterns of milk during breastfeeding and the infant's suckling pressure . The apparatus was previously used to investigate release of a Sulforhodamine B dye and of zinc sulphate from rapidly disintegrating tablets into human milk (Gerrard et al., 2012; Scheuerle et al., 2017) . The capability of non-woven fibres to release APIs into human milk was previously shown by Gerrard et al., who investigated the delivery of Sodium Dodecyl Sulphate (SDS) from loaded non-woven fibres (Bathfelt, Texel, Québec, Canada) located within a Sinnex filter holder, but without the use of breastfeeding simulation (Gerrard et al., 2012) . The following research builds on both studies and explored the fibrebased zinc sulphate delivery from a nipple shield device into human milk using the breastfeeding simulation apparatus. It is the first time that absolute recovery of the same compound using different dosage forms within the TNS has been quantitatively compared.
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Materials and methods

Materials
In accordance with previous fibre studies by Gerrard et al. (Gerrard et al., 2012) and characterized as outlined in previous literature (Scheuerle et al., 2017) , except that the fat content was calculated using an updated creamatocrit to fat correlation, published by Mitoulas et al. (Mitoulas et al., 2002) . Human milk used for experiments in this study had a protein content of 43.52 g l -1 , and a fat content of 16.51 g l -1 . Both values correspond to previously reported literature data (Emmett and Rogers, 1997; Kent et al., 2006; Saarela et al., 2005) 
Methods
Loading procedure
6.2 mg (standard deviation 0.075 mg, n = 3) and 6.4 mg (standard deviation 0.046 mg, n = 3) of elemental zinc was loaded through administration of a 49 % zinc sulphate monohydrate solution (wt/wt %) onto type A and B fibre mats, respectively. Values were based on the WHO dose recommendation of zinc sulphate as an adjunct to oral rehydration salts for the treatment of acute diarrhoea (World Health Organization, 2015) . All fibre mats were air dried in a petri dish for 24 hours at room temperature.
Scanning Electron Microscope analysis
Fibre mat cut-outs (diameter 10 mm), unloaded as well as loaded with zinc sulphate monohydrate respectively, were mounted on 12.5 mm Cambridge stubs with Silver Dag (Taab Ltd), sputter coated with 15 nm of iridium with a Quorum/Emitech K575X sputter coater, and viewed using a FEI Verios 460L Scanning Electron Microscope at 3 kV and 25 pA using a through lens detector operated in field free mode. Oregon, USA, v8.1). Thresholding was applied to separate the solid material from the pore space for a subvolume (0.998 mm 3 ) of the loaded and unloaded fibre mat. The volume and surface were calculated for the extracted solid material and the porosity was quantified by relating the volume of the pore space to that of the solid material.
Delivery and quantification
Calibration of the breastfeeding simulation apparatus' pumps prior to any experimental work being undertaken, as well as monitoring of temperature and pressure throughout the breastfeeding simulation was performed. Delivery of zinc was conducted in triplicate for each type of fibre mat by means of the breastfeeding simulation apparatus .
Based on literature about breastfeeding physiology (Black et al., 1998; Geddes et al., 2008; Macias and Meneses, 2011; Moral et al., 2010) , and in accordance with previous work conducted using the simulation apparatus (Gerrard and Larson, 2013; Scheuerle et al., 2017) were chosen for all experiments. The pressure range and amplitude were adjusted to values of physiological relevance (Geddes et al., 2008 min. This duration corresponds to double the time of an average breastfeed (Geddes et al., 2008) , and was chosen based on previously published breastfeeding simulation by Scheuerle et al. to allow for comparative analysis (Scheuerle et al., 2017) . All samples collected by the fraction collector were weighted using a Sartorius analytic balance (Epsom, UK), and subsequently stored at -80°C until further analysis. (Scheuerle et al., 2017) . The amount of elemental zinc loaded onto the non-woven fibre mats was evaluated as follows: Fibre mats were added to a vial containing 1 mL rinse of ultra-high purity water with 0.002% TritonX100. Following two 10-minute rounds of ultra-sonication, all vials were placed on a shaker plate for gentle shaking at night, and 1 mL of rinse was added during the day. This process was performed for a total of three nights/days, following which the samples were held in a 40°C water bath over night. After a 1:10 volumetric dilution in ultra-purity water, samples were diluted 1:20 volumetrically in a diluent, consisting of ultra-high purity water (Sartorius Stedium Biotech Arium pro UV Water polisher) with 0.002 % TritonX100 (Sigma-Aldrich, UK) and a standard of 1 ppm molybdenum (SPEX CertiPrep Metuchen, NJ). All sample solutions were vortexed using a Fisherbrand Whirlimixer (Loughborough, UK), and subsequently analysed according to the ICP-OES protocol as described by Scheuerle et al. (Scheuerle et al., 2017) . Data obtained was used to generate a release profile and to evaluate the cumulative zinc release.
Results and discussion
Scanning Electron Microscope analysis
SEM images of unloaded and zinc sulphate loaded Texel fibre mats type A and type B were obtained to explore the fibre mats morphology (see Figure 4 and Figure 5 ). It was found that despite their difference in g m -2 and thickness, both fibre mat types have the same fibrous structure and an approximate fibre diameter of 20 µm. Zinc sulphate was identified qualitatively 
X-ray Micro Computed Tomography
X-ray Micro Computed Tomography (XµCT) was used to investigate the fibre mats' porosity and 3D structure. Figure 9 shows examples of representative cross-sectional cuts through a swollen fibre cluster. The volume fraction, porosity, and total surface area were calculated for a cubical region of interest measuring 0.998 mm 3 from the fibre mats' centre (Table 1) . and fused with adjoined fibres to form high-density fibre clusters.
Release of zinc from non-woven fibres
The average total elemental zinc content loaded onto the fibre mat amounted to 6.17 ± 0.27 mg for fibre mat type A, and 6.4 ± 0.05 mg for fibre mat type B. The cumulative normalized proportion of zinc released and the normalized proportion of zinc released in individual fractions over time are illustrated in Figure 10 . The amount of human milk passed through the TNS, as well as the absolute recovery achieved for both fibre mat types are presented in Table 2 . Effectiveness and duration of release for both fibre mat types were comparable.
Page 17 of 24 Mat type A 64.00 ± 0.01 93.09 ± 1.08
Mat type B 61.64 ± 0.01 98.15 ± 0.97 Table 2 : Recovery achieved and human milk passed through the TNS for the delivery of zinc from Texel non-woven fibres using the breastfeeding simulation apparatus within the duration of 20 minutes (fractions of 40 s each with a total of 30 fractions).
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Full delivery of zinc into human milk within the duration of one breastfeed, as previously demonstrated to amount to 76.0 ± 12.6 g of human milk for 1-month-to 6-months-old infants (Kent et al., 2006) , has not been achieved. This could potentially be caused by milk components accumulating within the porous mat structure, thereby hampering the flow of milk through, and thus the delivery of zinc from the fibre network. The nature and absorption properties of the API significantly affect the release rate, however recent research appears to suggest that the lipid content and distribution within the milk influences the absolute recovery: Previous studies of SDS delivery from Texel non-woven fibres within a Sinnex filter holder into cow's milk have shown that absolute release was decreased to 30 -60 % when using non-homogenized milk (5.2 % fat) as opposed to 70 -90% for use of an homogenized form (3.6 % fat) (Gerrard et al., 2012) . SDS release of approximately 100 % into non-homogenized goat's milk (4.0 % fat) however, made Gerrard et al. conclude that in addition to the concentration and distribution of lipids, the overall milk composition, including carbohydrates, proteins, and lipids, has an impact on the API release rate from Texel non-woven fibres (Gerrard et al., 2012) .
Both observations present a challenge for the development of a standardized protocol for therapeutic release via non-woven Texel fibre mats, as human milk is a complex fluid with highly variable properties. To give but one example, absolute fat content of human milk can vary up to three fold, depending on the stage of lactation, dietary requirements and health status of the breastfeeding mother (Vir, 2011) . Potential surface modifications, such as plasma treatment, use of the wet chemical method, or graft polymerization of the fibres' surface (Ikada, 1994; Yoo et al., 2009) , could provide a means to address unwanted milk components accumulation while enhancing adsorption properties, yet thereby also increasing manufacturing effort and cost of production. Moreover, the obtained XμCT results also suggest that changes in fibre conformation are likely impacting the release properties of the Texel fibre mats. Given the decrease in porosity as a result of the zinc loading process, flow of human milk through the fibrous structure is restricted following loading, and can further be impacted by the accumulation of milk components. Previously, it was reported that the release from low surface area to volume hydroxypropylmethylcellulose tablets is slower (Reynolds et al., 2002) , and similarly, based on literature by Siepmann et al. (Siepmann and Siepmann, 2012) , the release from zinc-loaded fibre clusters with their reduced surface to volume ratio is believed to be slowed down. The XμCT data of unloaded fibre mats revealed the presence of fibres of higher density than originally expected based on the densities of viscose and polyester. In addition, fibre accumulation and/or the presence of impurities can be observed as indicated by the 10 -250 μm sized spots that are visible at medium density values in the XμCT data, believed to be a result of the fibres' manufacturing process, and/or caused by trapped dust particles. The even distribution of zinc within the fibre mat network of fibre mat type B in contrast to mat type A (Figure 8 ) is attributed to the larger fibre diameter and different wetting behaviour of the two fibre mats. The liquid absorption of the fibre mats as well as of the individual fibres is driven by capillary action and strongly influenced by the porosity of the samples (Chen et al., 1995) . It would also explain the unequal changes in porosity, surface area, and volume of fibre mat type A and B following loading, which however do not lead to an observed difference in release from both mats.
Overall, the absolute release of zinc from Texel non-woven fibres is 20 -48% superior compared to rapidly disintegrating tablets manufactured by direct compression: In a study by Scheuerle et al. achieved absolute recovery amounted to only 32 -51% (Scheuerle et al., 2017) .
It has to be noted that the total elemental zinc content of the rapidly disintegrating tablets (17.81 -18.21 mg) was higher than the amount of elemental zinc loaded onto the Texel nonwoven fibre mats used in this study (6.17-6.40 mg) (Scheuerle et al., 2017 ). Yet, while the main release from non-woven fibres occurred within the first 8 min, the release profile using rapidly disintegrating tables was linear, meaning that after 8 min the estimated elemental zinc content ranged between 2 -4 mg (Scheuerle et al., 2017) . This was significantly lower than the release from Texel non-woven fibre mats at 8 min. In addition to their superior release properties, the Important factors to be taken into consideration prior to in-vivo studies are fibre cohesion in order to exclude the possibility of fibre break-off, palatability, biocompatibility, and long-time stability. Moreover, use of different fibre materials, and different fibre types, such as fastdisintegrating electrospun fibres fabricated into non-woven film, could be investigated in future research.
Conclusions
Using a breastfeeding simulation apparatus to mimic the process of lactation and infant feeding, delivery of zinc sulphate from non-woven Texel fibre mats into human milk was investigated.
With an absolute elemental zinc recovery of 64% (fibre mat type A) and 62% (fibre mat type B) respectively in 93 g and 98 g of human milk passed through the fibre insert, full delivery within one breastfeed (approximately 76 g) has not been achieved. This can be attributed to the complex properties of human milk and accumulation of milk components within the porous mat structures, as well as structural changes of the fibre networks following loading, thereby hampering the delivery of zinc. In comparison to previous experiments however, the absolute zinc recovery using non-woven Texel fibre mats was identified as superior to the release by means of rapidly disintegrating tablets (Scheuerle et al., 2017) . Based on the non-woven fibre mats' release characteristics and cost-effectiveness, non-woven fibres can be regarded as an advantageous dosage form for oral drug delivery using the TNS. Further research will be required to establish Texel non-woven fibres as a generalized matrix for oral drug delivery, and to further explore alternative fibrous materials with advantageous characteristics for API delivery into human milk.
